🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Status
Completed
Location
US135
Start Date
2019-10-14
Trial ID
NCT04120194
Treatments Being Tested
The primary objectives of this study are to evaluate the humoral immunogeni...
Status
Completed
Location
CEI -Centro de Estudios Infectológicos
Start Date
2022-06-06
Trial ID
NCT05415462
Treatments Being Tested
This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...
Status
Completed
Location
AMR Tempe
Start Date
2022-08-25
Trial ID
NCT05501561
Treatments Being Tested
This phase 3 study is a randomized, double-blinded, comparator controlled, ...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2017-10-17
Trial ID
NCT03314662
Treatments Being Tested
This Phase 2, randomized, observer-blind, antigen and adjuvant dose-ranging...
Status
Completed
Location
03607 - PCRN_Paratus Clinical Research
Start Date
2021-04-13
Trial ID
NCT04782323
The purpose of this study is to evaluate the safety and efficacy of mRNA-10...
Status
Completed
Location
North Alabama Research Center, LLC
Start Date
2022-09-14
Trial ID
NCT05566639
Treatments Being Tested
Evaluate safety and immunogenicity of three influenza vaccines in children ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01992107
The purpose of this trial is to demonstrate the acceptable safety profile a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-18
Trial ID
NCT02207413
This Phase 2, randomized, observer-blind, active controlled clinical study ...
Status
Completed
Location
4022 - Coastal Clinical Research, an AMR company
Start Date
2020-10-08
Trial ID
NCT04576702
Treatments Being Tested